Randomised controlled trial: sequential vs. standard triple therapy for <i><scp>H</scp>elicobacter pylori</i> infection in Chinese children–a multicentre, open‐labelled study

Sitang Gong(Guangzhou Women and Children Medical Center), Liya Zhou(Peking University), Lanlan Geng(Guangzhou Women and Children Medical Center), Zhaolu Ding(Capital Medical University), Dan Li(Kaiser Permanente), Zilong Wang(Lanzhou University), Meng Mao(Guiyang Medical University), Xiping Xu, M Yang(Guangzhou Women and Children Medical Center), Z.‐L. Li(Peking University)
Alimentary Pharmacology & Therapeutics
October 5, 2013
10.1111/apt.12516
Cited by 23

Related Papers

A Lancet Commission on 70 years of women's reproductive, maternal, newborn, child, and adolescent health in China
|The Lancet|2021|579
Burosumab Therapy in Children with X-Linked Hypophosphatemia
|New England Journal of Medicine|2018|479
Prevalence of Autism Spectrum Disorder in China: A Nationwide Multi-center Population-based Study Among Children Aged 6 to 12 Years
|Neuroscience Bulletin|2020|468
Olig2 Targets Chromatin Remodelers to Enhancers to Initiate Oligodendrocyte Differentiation
|Cell|2013|384
Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial
|The Lancet|2019|375